Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced an upcoming ...

Thanks to the fundraising, the Barnstable Brown Diabetes Research Center at the University of Kentucky is studying the ...

Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that taletrectinib (IBTROZI®) has been added to the ...

That’s what the autoimmune disease lupus does, 1 and when it strikes, it can cause significant symptoms, including extreme ...

Keratinocytes can be productively infected by rabies virus, amplify viral load, and transmit virions to nearby nerve endings, ...

NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) ("NurExone" or the "Company"), a biopharmaceutical company developing ...

The patent, Australian Patent No. 2020303456, was granted on April 23, 2026 and is held by Technion Research and Development Foundation Limited. The patent relates to technology licensed exclusively ...

Expands access by 6 million covered lives, advancing commercial momentum for CNSide® in metastatic CNS cancers ...

This Boston-based biotech innovator in CNS disorders just reported significant insider selling amid a year of standout stock ...

VANCOUVER, BC / ACCESS Newswire / April 28, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery sys ...

Eli Lilly and Rigel Pharmaceuticals partnered in February 2021 to advance a pair of RIPK1 blockers, but the pharma in October ...

In vitro data demonstratedself-complementary AAV9 (scAAV9) enabled ~30-fold higher MeCP2 protein expression compared to single-stranded AAV9 ...